Active	Status	Sponsor type	Region	Phase	Filter
4 Active 1 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wang, Yanling
NCT05686642: Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke	Recruiting	2	300	RoW	LT3001 Drug:high dose, Placebo, LT3001 Drug:low dose	Shanghai Pharmaceuticals Holding Co., Ltd	Acute Ischemic Stroke	04/25	07/25